A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

被引：0
|
作者：
Kaisa Leea Sunela
Sanna Koskinen
Pirkko-Liisa Kellokumpu-Lehtinen
机构：
[1] Tampere University Hospital,Department of Oncology
[2] University of Tampere Medical School,Department of Oncology
[3] University of Tampere,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 66卷
关键词：
Renal cell carcinoma; Immunotherapy; Interferon; Pegylated; Chemotherapy; Capecitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 67
页数：8
相关论文
共 50 条
  • [41] Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
    Pagliaro, Lance C.
    Perez, Cherie A.
    Tu, Shi-Ming
    Daliani, Danal D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (06) : 487 - 491
  • [42] Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma
    Ulka N. Vaishampayan
    Lance K. Heilbrun
    Anthony F. Shields
    Jawana Lawhorn-Crews
    Karen Baranowski
    Daryn Smith
    Lawrence E. Flaherty
    Investigational New Drugs, 2007, 25 : 69 - 75
  • [43] An outpatient phase II study of subcutaneous interleukin-2 and interferon-alpha-2b in combination with intravenous vinblastine in metastatic renal cell cancer
    Pectasides, D
    Varthalitis, J
    Kostopoulou, M
    Mylonakis, A
    Triantaphyllis, D
    Papadopoulou, M
    Dimitriadis, M
    Athanassiou, A
    ONCOLOGY, 1998, 55 (01) : 10 - 15
  • [44] Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma
    Vaishampayan, Ulka N.
    Heilbrun, Lance K.
    Shields, Anthony F.
    Lawhorn-Crews, Jawana
    Baranowski, Karen
    Smith, Daryn
    Flaherty, Lawrence E.
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (01) : 69 - 75
  • [45] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Y H Park
    B-Y Ryoo
    S-J Choi
    H-T Kim
    British Journal of Cancer, 2004, 90 : 1329 - 1333
  • [46] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Park, YH
    Ryoo, BY
    Choi, SJ
    Kim, HT
    BRITISH JOURNAL OF CANCER, 2004, 90 (07) : 1329 - 1333
  • [47] A Phase II Study of Gemcitabine and Capecitabine in Patients With Advanced Renal Cell Cancer Southwest Oncology Group Study S0312
    Van Veldhuizen, Peter J.
    Hussey, Michael
    Lara, Primo N., Jr.
    Mack, Philip C.
    Gandour-Edwards, Regina
    Clark, Joseph I.
    Lange, Marianne K.
    Crawford, David E.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 453 - 459
  • [48] Phase II Trial of Pemetrexed Plus Gemcitabine in Patients With Locally Advanced and Metastatic Nonclear Cell Renal Cell Carcinoma
    Richey, Stephen L.
    Tamboli, Pheroze
    Ng, Chaan S.
    Lin, E.
    Lim, Zita D.
    Araujo, John C.
    Jonasch, Eric
    Sharma, Padmanee
    Pagliaro, Lance C.
    Tannir, Nizar M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 450 - 454
  • [49] PHASE-II STUDY WITH THE COMBINATION OF ETOPOSIDE, EPIRUBICINE AND CISPLATIN IN METASTATIC GASTRIC-CANCER
    ADENIS, A
    BONNETERRE, J
    PION, JM
    COLOMBEL, JF
    DESURMONT, P
    CARLIER, D
    PLANE, C
    DELZENNE, A
    BULLETIN DU CANCER, 1994, 81 (04) : 331 - 333
  • [50] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
12345